| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0199f84c3ee3a5a26126ea09bfe288c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02a85346f20a8aec02f7cd9e36c18ffb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34243ed5d528597b57990d6901da658f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8a6c6d9ec39ec3a66fe8023108c0747 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2012-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5881c6c45fd3173a9e2bbe5bac5d8d54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc48a3a6f7c9f2c24503f967824d9218
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_002a76c3f58e3de26944376d13ef81d1 |
| publicationDate |
2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012094615-A2 |
| titleOfInvention |
Use of cav3.1 selective t-type calcium channel antagonists |
| abstract |
The present invention is directed to heterocyclic compounds which are antagonists of T-type calcium channels and which are useful in the treatment and prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to methods of identifying a compound for the treatment and prevention of Alzheimer's Disease by investigating T-type calcium channel blocking activity of the compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110799215-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018200850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020517708-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11130750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427540-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324733-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022370443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018260699-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311522-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273218-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018200844-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7326159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018118101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2785125-C2 |
| priorityDate |
2011-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |